Newsletter | October 7, 2025

10.07.25 -- J&J Commits $2 Billion To N.C. Manufacturing Facility

SPONSOR

Looking for an alternative to shark squalene that gives you total peace of mind? Introducing Non Animal Origin Squalene Emprove® Expert – our new fermentation-produced squalene, suitable for high risk applications and use in vaccine adjuvants: excipient GMP according to IPEC-PQG Pharmaceutical Excipients GMP Guide / EXCiPACT® guidelines, ≥ 99.0% purity, low in endotoxins (≤ 2.25EU/mL) and bioburden, specified in the CoA, part of our Emprove® Expert portfolio for high-risk applications. More.

INDUSTRY INSIGHTS

Stop Managing CQV In Silos: Unify Your Validation Systems

Fragmented CQV systems hinder validation efforts, which risks compliance and slows progress. Discover how centralized platforms streamline processes and boost efficiency.

Advance Product Quality Through AVI And Future-Ready Infrastructure

Automated visual inspection combines robotics, precision imaging, and sophisticated defect-recognition software to provide a scalable solution for expanding pipelines and rises in production volumes.

Using Innovation To Accelerate And Optimize Your Scale-Up Strategy

Explore how AI, QbD, and digital transformation are reshaping manufacturing to accelerate scale-up, reduce defects, and optimize batch release for faster, more resilient operations.

FEATURED EDITORIAL

J&J Commits $2 Billion To N.C. Manufacturing Facility

J&J’s latest announcement follows its commitment in March to invest $55 billion to support U.S. manufacturing, R&D, and technology over the next four years.

INDUSTRY INSIGHTS CONTINUED

Future-Proofing A Volatile Supply Chain Through Modular Biomanufacturing

Biopharmaceutical supply chain volatility is at an all-time high. To navigate this complexity, examine how CDMOs must prioritize robust sourcing strategies and proactive vendor management.

Balancing Protein A Resin Cost, Performance, And Productivity

Optimizing input parameters like DBC, flow rate, and resin durability is key to boosting productivity in downstream bioprocessing. Uncover how to tailor resin choices to meet your specific requirements.

Simplifying Antibody-Drug Conjugate Payload Synthesis

ADC's offer precise, targeted therapy by delivering cytotoxic agents directly to diseased cells. Learn how this method minimizes harm to healthy tissue and revolutionizes treatment for cancer.

Evolving Containment In Pharma Manufacturing Facilities

Here, we characterize the new production directions in pharmacy and describe the flexible equipment to improve pharma efficiency, purity, and production safety in the coming decade.

Helping Deliver A Patient-Centric Future For OSD Manufacturing

Drug developers and manufacturers must address several key challenges, including formulation complexity, improving bioavailability of poorly soluble compounds, and optimizing drug release profiles.

Applying Automation To The Manufacture Of Drug Delivery Devices

Automated manufacturing is a powerful but often misunderstood tool available to produce drug delivery and other pharmaceutical devices — whether established designs or innovative new ideas.

Engineering Challenges Of Designing Pharmaceutical Isolators

Designing isolators requires navigating complex engineering hurdles, from ensuring chemical compatibility to optimizing airflow and pressure. Explore the considerations that guarantee safety.

Formulation And Evaluation Of Enteric Coated Aspirin Capsules

Enteric polymer coatings play a crucial role in oral drug formulations, protecting the API from harsh gastric conditions and enabling targeted drug delivery with optimized release based on location.

SPONSOR

Webinar: AI In Action: Driving Operational Excellence in Life Sciences

Discover how CAI and phData are redefining compliance and operational readiness in life sciences. Join our webinar to see how advanced AI solutions slash manual effort, expedite facility readiness, and improve accuracy in regulated environments. Learn from real-world case studies where thousands of labor hours were reduced to hours—freeing teams to focus on higher-value activities. Click here to learn more.

SOLUTIONS

Biopharmaceutical Process And Manufacturing Technology Services

Fostering A Collaborative, Cross-Functional Approach

Spore Suspensions

Proven Vial Containment That Scales From R&D To Commercial

Connect With Pharmaceutical Online: